A method for constructing a neonatal hemorrhagic hydrocephalus model

By using LPA receptor activator to construct a hemorrhagic hydrocephalus model in zebrafish, the problem of lack of this model in the prior art was solved, and a stable and simplified experimental process was achieved to provide hydrocephalus after bleeding in neonatal Research provides powerful tools.

CN117751892BActive Publication Date: 2024-11-19BRAIN-COMPUTER INTERACTION & HUMAN-COMPUTER INTEGRATION HAIHE LAB
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202410166408.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-02-06
Publication Date
2024-11-19
Estimated Expiration
2044-02-06

AI Technical Summary

Technical Problem

There is currently no method to construct a hemorrhagic hydrocephalus model in zebrafish, and it is difficult to study the pathogenesis of hydrocephalus after neonatal bleeding and develop treatment methods.

Method used

The LPA receptor activator reacts with NaOH to generate a LPA receptor activator salt solution. A newborn hemorrhagic hydrocephalus model was constructed through administration. Zebrafish as experimental animals were used to verify the enlargement of the ventricle through pathological morphology.

Benefits of technology

An animal model of hemorrhagic hydrocephalus in neonatal well-repeated is successfully constructed, which simplifies the experimental process and reduces interference factors, providing an experimental basis for studying the mechanism and treatment of hydrocephalus after neonatal hemorrhage.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117751892B_ABST
    Figure CN117751892B_ABST
Patent Text Reader

Abstract

The present invention discloses a method for constructing a neonatal hemorrhagic hydrocephalus model, comprising the following steps: (1) reacting an LPA receptor activator with NaOH in a molar mass ratio of 1:1 to prepare an LPA receptor activator saline solution; (2) administering the LPA receptor activator saline solution to experimental animals under suitable feeding conditions; (3) after the experimental animals are treated with the LPA receptor activator saline solution, experimental verification is performed through pathological morphology; (4) compared with the control group, the pathological morphology shows that the cerebral ventricle of the zebrafish is significantly enlarged. If this condition is met, the neonatal hemorrhagic hydrocephalus animal model is successfully constructed. The present invention adopts the above-mentioned method for constructing a neonatal hemorrhagic hydrocephalus model, selects zebrafish as experimental animals, and constructs a neonatal hemorrhagic hydrocephalus model using an LPA receptor activator. The method has good stability and repeatability, is objective and simple, has strong operability, and reduces other possible interference factors.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of disease animal models, in particular to a method for constructing a neonatal hemorrhagic hydrocephalus model. Background Art

[0002] Hydrocephalus is one of the most common neurodevelopmental defects, occurring in 1-3 per 1,000 births. It is characterized by cerebrospinal fluid-filled and enlarged ventricles in the brain, leading to severe mental retardation and motor dysfunction. Known causes of hydrocephalus include infection, brain trauma, and genetic mutations. Hydrocephalus can be categorized as either flow-through or non-flow-through, depending on whether there is structural obstruction to cerebrospinal fluid flow.

[0003] Disruption of the structural integrity of the ventricular system can cause non-communicating hydrocephalus; excessive secretion of cerebrospinal fluid from the choroid plexus, inefficient reabsorption of cerebrospinal fluid by the subarachnoid villi, and defective cerebrospinal fluid flow can lead to communicating hydrocephalus. Ependymal cells, derived from the neuroepithelium and lining the surface of the ventricles, are closely associated with hydrocephalus caused by ciliary defects. More seriously, failure of ependymal cells to form, mature, and remain intact can lead to early-onset fetal hydrocephalus through aqueductal stenosis, which blocks cerebrospinal fluid flow through the narrow channel between the third and fourth ventricles. Currently, the pathogenesis of neonatal hydrocephalus remains unclear, but animal models can provide new insights into the pathogenesis of the disease and lay the foundation for the development of new treatments.

[0004] A clear cause of hydrocephalus is hemorrhage within the fetal ventricles or brain tissue, suggesting that factors or components in the blood may trigger the development of this serious neurological disorder. Lysophosphatidic acid (LPA), a blood-borne signaling lipid, levels of which increase during hemorrhage or trauma. Intraventricular delivery of LPA in a mouse model of post-hemorrhagic hydrocephalus in newborns, destroys neural progenitor cells. Concurrently, exposing the mouse brain to LPA can cause fetal hydrocephalus in mice. However, there is currently no method for constructing a fetal hydrocephalus model in zebrafish.

[0005] As a model organism, zebrafish are widely used in constructing disease models due to their in vitro fertilization, transparent embryos, low breeding costs, and strong regenerative capacity. This paper proposes a new method for constructing an animal model of neonatal hemorrhagic hydrocephalus using an LPA receptor activator. Summary of the Invention

[0006] The present invention aims to provide a method for constructing a neonatal hemorrhagic hydrocephalus model. The method uses zebrafish as experimental animals and utilizes an LPA receptor activator to construct the neonatal hemorrhagic hydrocephalus model. The method has good stability and repeatability, is objective and simple, has strong operability, and reduces other possible interfering factors.

[0007] To achieve the above object, the present invention provides a method for constructing a neonatal hemorrhagic hydrocephalus model, comprising the following steps:

[0008] (1) reacting an LPA receptor activator with NaOH at a molar mass ratio of 1:1 to prepare an LPA receptor activator salt solution;

[0009] (2) Under appropriate feeding conditions, the experimental animals were administered LPA receptor activator saline solution;

[0010] (3) Experimental verification by pathomorphology after experimental animals were treated with LPA receptor activator saline solution;

[0011] (4) Pathomorphology Compared with the control group, the zebrafish ventricles were significantly enlarged. If this condition was met, the animal model of neonatal posthemorrhagic hydrocephalus was successfully constructed.

[0012] Preferably, in step (2), the experimental animal is zebrafish.

[0013] Preferably, in step (2), the LPA receptor activator saline solution is administered at a concentration of 5 ug / mL.

[0014] Preferably, in step (2), the LPA receptor activator saline solution is administered by immersion.

[0015] Preferably, in step (2), the rearing conditions are: temperature 28.5°C, 14 hours of light / 10 hours of darkness.

[0016] The advantages and positive effects of the method for constructing a neonatal hemorrhagic hydrocephalus model described in the present invention are:

[0017] 1. The present invention adopts a non-invasive method to construct an animal model of neonatal hemorrhagic hydrocephalus, applies LPA receptor activators to the construction of the animal model of neonatal hemorrhagic hydrocephalus, and successfully establishes an animal model of neonatal hemorrhagic hydrocephalus by immersing the animal model in LPA receptor activators while reducing damage to the animal model. The model has good stability and repeatability, is objective and simple, has strong operability, and reduces other possible interfering factors, providing the necessary experimental basis for studying the mechanism of neonatal hemorrhagic hydrocephalus and the development of treatment methods.

[0018] 2. The present invention uses zebrafish to construct a neonatal hemorrhagic hydrocephalus model. As a model animal, zebrafish has the advantages of low breeding cost, transparent embryos, and strong reproductive capacity. With the completion of zebrafish whole genome sequencing, zebrafish as a model animal has been widely used to construct disease models, explore disease mechanisms and screen therapeutic drugs. Compared with mice, zebrafish have an absolute advantage in the ease of breeding and modeling. In addition, zebrafish develop rapidly and can simulate human diseases and drug treatments in the embryonic and adult stages.

[0019] The technical solution of the present invention is further described in detail below through the accompanying drawings and embodiments. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] Figure 1 Flowchart for constructing an animal model of neonatal posthemorrhagic hydrocephalus for the present invention;

[0021] Figure 2 The results of cerebral ventricle detection in the model group and the blank control group according to the embodiment of the present invention are shown in FIG.

[0022] Figure 3 These are images of the zebrafish ventricles under a stereomicroscope according to an embodiment of the present invention, wherein A is an image of the zebrafish ventricles in the blank control group, and B is an image of the zebrafish ventricles in the model group (5 μg / mL). DETAILED DESCRIPTION

[0023] The technical solution of the present invention is further described below with reference to the accompanying drawings and embodiments.

[0024] Unless otherwise defined, technical or scientific terms used in the present invention shall have the same meaning as commonly understood by one of ordinary skill in the art to which the present invention belongs.

[0025] like Figure 1 As shown, a method for constructing a neonatal hemorrhagic hydrocephalus model comprises the following steps:

[0026] (1) First, the LPA receptor activator and NaOH were reacted at a molar mass ratio of 1:1, and then dissolved in E3 to 5 μg / mL to prepare an LPA receptor activator salt solution.

[0027] LPA receptor activators can also be combined with one or more pharmaceutically acceptable carriers; carriers include conventional diluents, excipients, fillers, binders, wetting agents, disintegrants, absorption enhancers, surfactants, adsorption carriers, lubricants, etc. in the pharmaceutical field.

[0028] LPA receptor activators can be combined with carriers to form various forms such as injections, tablets, powders, granules, capsules, oral solutions, ointments, creams, etc.; various dosage forms of drugs can be prepared according to conventional methods in the pharmaceutical field and can be introduced into the body by injection, spraying, nasal drops, eye drops, penetration, absorption, physical or chemical mediation methods such as muscle, intradermal, subcutaneous, intravenous, and mucosal tissues; or they can be mixed or encapsulated with other substances and then introduced into the body.

[0029] (2) Under suitable rearing conditions, the rearing conditions are: temperature 28.5°C, 14 hours of light / 10 hours of darkness, and LPA receptor activator saline solution is administered to the experimental animals. The experimental animals are zebrafish. The concentration of the LPA receptor activator saline solution is 5 μg / mL, and the LPA receptor activator saline solution is administered by immersion.

[0030] (3) The experimental animals were treated with LPA receptor activator saline solution and the results were verified by pathomorphological methods.

[0031] (4) Pathomorphological indicators: Compared with the control group, the zebrafish ventricles were significantly enlarged. If this condition is met, the animal model of neonatal hemorrhagic hydrocephalus is successfully constructed.

[0032] Example

[0033] Unless otherwise specified, the instruments, equipment and reagents used in this example were commercially available.

[0034] Experimental animals: 4-hour-old zebrafish embryos.

[0035] Experimental materials: LPA receptor activator; stereo microscope; zebrafish behavior recorder. The chemical formula of LPA receptor activator is as follows:

[0036]

[0037] (1) Preparation of zebrafish larvae

[0038] Wild-type zebrafish were obtained from the China Zebrafish Resource Center and maintained according to standard protocols. The fish were maintained at 28°C under 14-hour light / 10-hour dark conditions. Zebrafish embryos were obtained by natural mating, washed, and maintained in E3 medium (5 mM NaCl, 0.17 mM KCl, 0.4 mM CaCl₂, and 0.33 mM MgSO₄) containing 2 mg / L methylene blue. The medium pH was maintained at 7.1 and was replaced daily.

[0039] (2) Experimental grouping and treatment

[0040] a. Model group: 4-hour-old zebrafish embryos were randomly transferred to a 24-well cell culture plate, with 15 eggs per well. The embryos were exposed to 5 μg / mL of LPA receptor activator saline solution, which was prepared by E3 (5 mM NaCl, 0.17 mM KCl, 0.4 mM CaCl2 and 0.33 mM MgSO4).

[0041] b. Blank control group: 4-hour-old zebrafish embryos were randomly transferred to a 24-well cell culture plate, with 15 eggs per well, and the embryos were placed in E3 solution.

[0042] (3) Imaging the zebrafish ventricle using a stereomicroscope

[0043] like Figure 2-3 As shown, at 72 hours of embryonic development, embryos were embedded in low-melting-point agarose and set aside for later use. After the stereomicroscope was adjusted, images of the zebrafish ventricles were acquired. Ventricular size was measured using Image J.

[0044] In summary, the neonatal hemorrhagic hydrocephalus animal model prepared by the present invention can monitor the degree of hydrocephalus in real time by measuring the size of the ventricles during the research process. The modeling process of the present invention is a dynamic process, and the ventricular dilation at different time points can be observed, which provides a good experimental platform for studying neonatal hemorrhagic hydrocephalus. At the same time, this model also provides a good tool for developing new treatment methods.

[0045] Therefore, the present invention adopts the above-mentioned method for constructing a neonatal hemorrhagic hydrocephalus model, selects zebrafish as experimental animals, and uses LPA receptor activators to construct a neonatal hemorrhagic hydrocephalus model, which has good stability and repeatability, is objective and simple, has strong operability, and reduces other possible interference factors.

[0046] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention rather than to limit the same. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that they can still modify or replace the technical solutions of the present invention with equivalents, and these modifications or equivalent replacements cannot cause the modified technical solutions to deviate from the spirit and scope of the technical solutions of the present invention.

Claims

1. A method for constructing a neonatal hemorrhagic hydrocephalus model, characterized in that: The steps include: (1) reacting an LPA receptor activator with NaOH at a molar mass ratio of 1:1 to prepare an LPA receptor activator salt solution; (2) Under appropriate feeding conditions, the experimental animals were administered LPA receptor activator saline solution; the feeding conditions were: temperature 28.5°C, 14 hours of light / 10 hours of darkness, the administration concentration of the LPA receptor activator saline solution was 5 ug / mL, the experimental animals were zebrafish, and the LPA receptor activator saline solution was administered by immersion; (3) Experimental verification was performed by pathomorphological methods after experimental animals were treated with LPA receptor activator saline solution; (4) Pathomorphology Compared with the control group, the cerebral ventricles of zebrafish were significantly enlarged. If this condition was met, the animal model of neonatal hemorrhagic hydrocephalus was successfully established.

Citation Information

Cited By

  • Application of conivaptan hydrochloride in preparation of medicine for treating degenerative brain diseases

    CN122229849A